Tag - MultiStem Cell Therapy

Feature

Athersys poised to launch pivotal stroke study next summer

By Len Zehr After receiving a Special Protocol Assessment (SPA) from the FDA at the end of September, Athersys (NASDAQ:ATHX) hopes to launch a pivotal trial next summer administering its intravenous MultiStem cell...

December 13, 2016

Feature

Enrollment in Athersys stroke trial nears completion

By Len Zehr Athersys (NASDAQ:ATHX) expects to complete enrollment by the end of the summer in a Phase 2 clinical trial of its MultiStem cell therapy in about 140 moderate to moderately-severe ischemic stroke patients...

May 27, 2014

Tag - MultiStem Cell Therapy

Athersys poised to launch pivotal stroke study next summer

Enrollment in Athersys stroke trial nears completion

General

More